Skip to main content

Silvercrest Asset Management Group LLC

SEC CIK
0001232395
Latest filing
Aug 14, 2026

PCRX holding history

Pacira BioSciences, Inc. in every 13F filed by Silvercrest Asset Management Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PCRX overviewAll 13F holders of PCRXFull Q2 2026 holdings

Shares (Q3 2023)
0
Sold out in Q3 2023
Value
$0
% of portfolio
0.0%
Quarters held
10
Since Q1 2021
Holdings of PCRX by Silvercrest Asset Management Group LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20230$00.0%−122,854−100.0%Sold outHolders
Q2 2023122,854$4.92M<0.1%+18,596+17.8%AddedHolders
Q1 2023104,258$4.25M<0.1%−113−0.1%ReducedHolders
Q4 2022104,371$4.03M<0.1%−171,080−62.1%ReducedHolders
Q3 2022275,451$14.7M0.1%−14,859−5.1%ReducedHolders
Q2 2022290,310$16.9M0.1%−7,926−2.7%ReducedHolders
Q1 2022298,236$22.8M0.1%−56,370−15.9%ReducedHolders
Q4 2021354,606$21.3M0.1%+78,559+28.5%AddedHolders
Q3 2021276,047$15.5M0.1%−16,509−5.6%ReducedHolders
Q2 2021292,556$17.8M0.1%−20,288−6.5%ReducedHolders
Q1 2021312,844$21.9M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.